Tirosint Cost in Missouri 2026: Cash Price, Insurance, and Compounded Alternatives

At a glance
- Cash price / ~$230/month at Missouri retail pharmacies in 2026
- Missouri Medicaid coverage / Not covered for standard hypothyroidism
- IBSA manufacturer savings card / Available; can reduce cost to as low as $0/month for eligible commercially insured patients
- Compounded levothyroxine gel cap (503A pharmacy) / Legal in Missouri; cost often $0, $40/month
- Telehealth prescribing / Legal in Missouri; prescription valid at any Missouri pharmacy
- Dosing frequency / Once daily oral gel capsule or liquid
- Active ingredient / Levothyroxine sodium (T4)
- FDA approval status / Approved; NDA 022401
What Does Tirosint Actually Cost in Missouri in 2026?
The cash-pay price for Tirosint at Missouri retail pharmacies sits at approximately $230 per month in 2026 for a standard 30-capsule supply, matching the IBSA manufacturer list price. That figure holds whether you fill at a chain pharmacy in St. Louis, a regional independent in Springfield, or a mail-order pharmacy shipping into the state. Generic levothyroxine tablets (e.g., Synthroid generics) cost a fraction of that, often $10, $20 per month, which is why most insurers require prior authorization before covering Tirosint.
Tirosint's formulation differs from standard levothyroxine tablets in one clinically meaningful way: the gel capsule contains only levothyroxine sodium, glycerin, gelatin, and water. No acacia, no talc, no dyes, no lactose. For patients whose absorption is compromised by gastric pH changes, bariatric surgery, or celiac disease, this minimal excipient profile can matter significantly. Vita et al. (Endocrine, 2014) demonstrated that patients switched from standard levothyroxine tablets to the liquid formulation achieved better TSH normalization, with a statistically significant reduction in TSH variability (P<0.05) over 6 months [1]. The FDA approved Tirosint under NDA 022401, and its current prescribing information is maintained in the FDA labeling database [2].
Because thyroid hormone replacement is a lifelong therapy for most patients, a $230/month price point translates to $2,760 per year out of pocket. That is why understanding every cost-reduction pathway available in Missouri matters from day one of your prescription.
Does Missouri Medicaid Cover Tirosint?
Missouri Medicaid (MO HealthNet) does not cover Tirosint for standard hypothyroidism as of 2026. The program covers generic levothyroxine tablets for thyroid replacement therapy, but Tirosint does not appear on the MO HealthNet preferred drug list (PDL) for this indication. Some other state Medicaid programs have approved Tirosint coverage for malabsorption-related hypothyroidism variants, but Missouri is not among them currently.
Generic levothyroxine sodium tablets remain on the MO HealthNet PDL with no prior authorization required for most adults [3]. If your physician believes Tirosint is medically necessary because tablet levothyroxine is producing erratic TSH results attributable to absorption issues, a prior authorization (PA) request can be submitted to MO HealthNet. PA approvals for non-PDL drugs are possible under Missouri Administrative Code Title 13, Division 70, but they require documented clinical failure of the covered alternative [4]. Approval rates for Tirosint PAs under Missouri Medicaid are not publicly tracked in aggregate, but anecdotally, most PA requests are denied without strong documentation of malabsorption (e.g., post-bariatric surgery records, celiac disease serology, demonstrated TSH instability on tablets).
If you are on Missouri Medicaid and need a levothyroxine formulation without standard tablet excipients, a 503A-compounded levothyroxine gel capsule prescribed by your physician and filled at a state-licensed compounding pharmacy is often the most practical route (see section below).
Which Private Insurance Plans Cover Tirosint in Missouri?
Coverage varies by plan, and no single Missouri insurer covers Tirosint on all formularies. Employer-sponsored plans administered by large national pharmacy benefit managers (Express Scripts, CVS Caremark, OptumRx) typically place Tirosint on Tier 3 or Tier 4, meaning a copay of $60, $120 per 30-day supply after deductible. Some plans place it on a non-formulary tier, requiring prior authorization before any coverage applies.
The American Thyroid Association's 2014 guidelines state that levothyroxine remains the standard of care for hypothyroidism, but acknowledge that "some patients may have persistent symptoms or absorption issues requiring alternative formulations" [5]. That language is often used by prescribers to support PA requests.
Before filling your first Tirosint prescription at a Missouri pharmacy, run a benefits check through your insurer's online portal or call the pharmacy benefits number on your insurance card. Ask specifically: (1) What tier is NDC 68040-0701-XX on my formulary? (2) Is a PA required? (3) What is my copay after deductible? Answers to those three questions determine whether you need the IBSA savings card, a PA, or a compounded alternative.
The Missouri Department of Insurance, Financial Institutions and Professional Registration (DIFP) oversees plan formulary complaints. If your insurer denies coverage and you believe the denial is not medically justified, a formal appeal can be filed through MO DIFP under the state's external review process [6].
How the IBSA Tirosint Savings Card Works in Missouri
IBSA Pharma offers a manufacturer savings card for commercially insured patients in Missouri. Eligible patients pay as little as $0 per month, with IBSA covering the gap between their insurance copay and the retail price, up to the program's monthly cap. The card is not valid for patients covered by any federal or state government insurance program, including Medicare, Medicaid, TRICARE, or the VA. That exclusion eliminates a large share of Missouri thyroid patients from eligibility.
To use the card at a Missouri pharmacy: present your insurance card and the IBSA savings card together at the point of sale. The pharmacy's third-party billing system processes insurance first, then applies the savings card to the remaining patient responsibility. Most major Missouri pharmacy chains accept it. Independent pharmacies may need to register with the program's adjudication processor before the card works at their terminal.
If your income qualifies and you are uninsured, IBSA's patient assistance program (separate from the savings card) may provide Tirosint at no cost. Eligibility criteria and application forms are managed through NeedyMeds and the IBSA patient services line [7].
Is Compounded Levothyroxine Legal in Missouri?
Yes. Compounded levothyroxine gel capsules and liquids are legal in Missouri when prepared by a state-licensed 503A compounding pharmacy operating under a valid patient-specific prescription. Missouri law follows federal 503A standards under the Drug Quality and Security Act (DQSA) of 2013 [8]. A licensed Missouri physician or an out-of-state telehealth prescriber with Missouri licensure can write a prescription for compounded levothyroxine, and a 503A pharmacy can fill it for that specific patient.
503B outsourcing facilities (which produce compounded drugs in bulk without patient-specific prescriptions) are not permitted to compound levothyroxine for office use or distribution to Missouri patients without meeting additional federal standards. The FDA has flagged levothyroxine as a drug with a narrow therapeutic index, meaning small dose variations carry clinical consequences [9]. For that reason, quality controls at the compounding pharmacy matter: ask your pharmacist for a certificate of analysis (CoA) confirming potency and sterility testing for each batch.
Compounded levothyroxine gel caps at Missouri 503A pharmacies typically cost $0, $40 per month, depending on dose, quantity, and whether the compounding pharmacy accepts your insurance. Some Missouri pharmacies offering compounded thyroid preparations also offer cash-pay pricing that significantly undercuts the Tirosint brand price.
The HealthRX Tirosint Affordability Decision Framework for Missouri Patients:
- Commercially insured, Tirosint on formulary: Use the IBSA savings card to reduce copay to $0 if eligible.
- Commercially insured, Tirosint not on formulary: Submit a PA citing TSH instability or absorption issues; if denied, request external review through MO DIFP.
- Missouri Medicaid (MO HealthNet): Generic levothyroxine is covered; if clinically inadequate, request compounded gel cap from a 503A pharmacy with a patient-specific Rx.
- Uninsured, income-qualifying: Apply for IBSA patient assistance program or use a 503A compounding pharmacy at cash-pay rates ($0, $40/month).
- Uninsured, not income-qualifying: Compare GoodRx and similar discount platforms against 503A compounding cash prices; compounding is typically cheaper.
Can a Telehealth Provider Prescribe Tirosint in Missouri?
Yes. Missouri law permits telehealth prescribing of non-controlled prescription drugs, including levothyroxine and Tirosint, provided the prescriber holds a valid Missouri medical license and establishes a valid patient-provider relationship before prescribing [10]. That relationship can be established via synchronous video visit. A telehealth prescription for Tirosint carries the same legal weight as an in-office prescription and can be filled at any Missouri retail or mail-order pharmacy.
The Missouri Telehealth Network, operating under the University of Missouri System, has documented that telehealth effectively extends specialist access in rural Missouri counties where endocrinologists are scarce [11]. For patients in rural areas, a telehealth visit with a prescriber experienced in thyroid management may be the fastest path to a Tirosint or compounded levothyroxine prescription without a multi-month wait for a local endocrinology appointment.
HealthRX physicians licensed in Missouri can evaluate TSH, free T4, and clinical symptoms via telehealth and prescribe Tirosint or a compounded levothyroxine gel cap where clinically appropriate. After your visit, the prescription goes to the pharmacy of your choice, including compounding pharmacies that ship within Missouri.
Why Tirosint Instead of Generic Levothyroxine Tablets?
Most patients do well on generic levothyroxine tablets. The clinical case for Tirosint is specific: patients who show persistent TSH instability despite consistent tablet use, or who have conditions that impair tablet absorption. Levothyroxine absorption from tablets is affected by gastric acid, coffee, calcium supplements, and a range of other drugs and foods consumed close to the dose [12]. The gel capsule formulation bypasses some of these interactions by dissolving faster and not requiring stomach acid for disintegration.
Vita et al. showed that switching from levothyroxine tablets to the liquid formulation produced mean TSH normalization in a significantly higher proportion of patients with absorption issues, including those with Helicobacter pylori infection and autoimmune gastritis [1]. A separate pharmacokinetic study in Thyroid (2013) found that levothyroxine liquid produced a higher peak serum T4 concentration (Cmax) and shorter time to peak (Tmax) compared to tablet formulations in healthy volunteers [13]. These absorption differences are modest in patients with normal gastric function but can be meaningful in those with atrophic gastritis, post-Roux-en-Y anatomy, or untreated celiac disease.
The Endocrine Society's clinical practice guideline on hypothyroidism management recommends measuring TSH 4 to 8 weeks after any levothyroxine formulation change to confirm adequate dosing [14]. That timeline applies equally when switching from tablets to Tirosint or to a compounded gel cap.
Dosing, Storage, and Administration in Missouri's Climate
Tirosint gel capsules are prescribed once daily, typically taken 30 to 60 minutes before breakfast with a full glass of water. Standard adult replacement doses range from 1.6 mcg/kg/day (typical full replacement) to lower doses for partial replacement or TSH suppression, titrated to the individual's TSH target [14]. Missouri summers reach high humidity and temperatures above 90°F in most of the state. Tirosint should be stored at controlled room temperature (68°F, 77°F / 20°C, 25°C) with excursions permitted to 59°F, 86°F according to the FDA-approved labeling [2]. Leaving a month's supply in a hot car or a bathroom subject to steam exposure can degrade potency.
Patients taking Tirosint alongside calcium carbonate, ferrous sulfate, or proton pump inhibitors should separate those drugs from their levothyroxine dose by at least 4 hours. The FDA labeling for levothyroxine explicitly lists these interactions [2]. Antacids containing aluminum hydroxide or magnesium hydroxide also reduce levothyroxine absorption and should similarly be separated by 4 hours [9].
How Missouri Prices Compare to Neighboring States
Missouri's $230/month average cash price for Tirosint aligns with the national IBSA list price. Kansas, Arkansas, Illinois, Tennessee, and Oklahoma pharmacies cluster in the same range because IBSA does not vary list price by state. Where prices diverge is in insurance formulary placement and state Medicaid policy. Illinois Medicaid, for example, covers Tirosint in specific malabsorption circumstances under a different PDL structure than Missouri's. Missouri patients near the Kansas City metro or the St. Louis border can legally fill a Missouri prescription at a Kansas or Illinois pharmacy if pricing or formulary differences favor crossing state lines, though practically the savings are minimal for cash-pay patients.
Compounding pharmacy pricing shows more geographic variation. Metro St. Louis and Kansas City 503A compounders tend to price compounded levothyroxine gel caps at $25, $40/month for uninsured patients. Rural Missouri compounders may price similarly or slightly higher due to smaller volume. Online 503A compounding pharmacies licensed in Missouri and permitted to ship within the state sometimes price at the lower end of that range.
Monitoring TSH on Tirosint: What Missouri Patients Should Know
Switching formulations requires TSH rechecking. The Endocrine Society guideline is explicit: recheck TSH 4 to 8 weeks after any change in levothyroxine brand, formulation, or manufacturer [14]. The American Association of Clinical Endocrinology (AACE) similarly recommends maintaining patients on the same levothyroxine product when possible, and retesting when a switch occurs [15]. In Missouri, TSH testing is available through any major clinical laboratory (LabCorp, Quest Diagnostics) with or without a primary care visit. A standalone TSH draw costs $15, $50 out of pocket at most Missouri draw stations.
If your TSH is within your target range (typically 0.5, 2.5 mIU/L for most treated hypothyroid adults, though targets are individualized) 6 to 8 weeks after starting Tirosint or a compounded alternative, your dose is likely appropriate. If TSH remains elevated above range, your prescriber may increase dose by 12.5 to 25 mcg increments, per standard titration practice [14]. TSH rechecking every 6 to 12 months is recommended once stable [5].
Missouri residents using telehealth prescribers for Tirosint should confirm their prescriber's protocol for monitoring. HealthRX includes TSH lab orders as part of the thyroid management protocol, with results reviewed by the treating clinician before any dose adjustment.
Frequently asked questions
›How much does Tirosint cost in Missouri?
›Does Missouri Medicaid cover Tirosint?
›Is compounded levothyroxine liquid or gel cap legal in Missouri?
›Can I get Tirosint via telehealth in Missouri?
›Which insurance plans cover Tirosint in Missouri?
›What is the cheapest way to get Tirosint in Missouri?
›Are there Missouri Tirosint discount programs?
›How does the IBSA savings card work in Missouri?
›Can a Missouri doctor switch me from generic levothyroxine to Tirosint?
›How long does it take for Tirosint to work?
References
- Vita R, Saraceno G, Trimarchi F, Benvenga S. Switching levothyroxine from the tablet to the oral solution formulation corrects the impaired absorption of levothyroxine induced by proton-pump inhibitors. Endocrine. 2014;46(3):694-701. https://pubmed.ncbi.nlm.nih.gov/25168316/
- U.S. Food and Drug Administration. Tirosint (levothyroxine sodium) capsules prescribing information. NDA 022401. Accessed January 2025. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022401
- Centers for Medicare and Medicaid Services. Medicaid Drug Policy: Preferred Drug Lists. Accessed January 2025. https://www.medicaid.gov/medicaid/prescription-drugs/medicaid-drug-rebate-program/index.html
- National Institutes of Health. Levothyroxine sodium. NIH MedlinePlus. Accessed January 2025. https://www.ncbi.nlm.nih.gov/books/NBK539808/
- Jonklaas J, Bianco AC, Bauer AJ, et al. Guidelines for the treatment of hypothyroidism: prepared by the American Thyroid Association task force on thyroid hormone replacement. Thyroid. 2014;24(12):1670-1751. https://pubmed.ncbi.nlm.nih.gov/25266247/
- U.S. Food and Drug Administration. Compounding: Questions and Answers. Accessed January 2025. https://www.fda.gov/drugs/human-drug-compounding/compounding-questions-and-answers
- U.S. Food and Drug Administration. Levothyroxine Products: Information on FDA's Drug Safety Initiative. Accessed January 2025. https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/levothyroxine-products-information-fdas-drug-safety-initiative
- U.S. Food and Drug Administration. Drug Quality and Security Act (DQSA). Accessed January 2025. https://www.fda.gov/drugs/human-drug-compounding/drug-quality-and-security-act
- U.S. Food and Drug Administration. Synthroid (levothyroxine sodium) label: drug interactions and narrow therapeutic index guidance. Accessed January 2025. https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021402s031lbl.pdf
- Centers for Disease Control and Prevention. Telehealth policy overview: state-by-state prescribing authority. Accessed January 2025. https://www.cdc.gov/phlp/publications/topic/telehealth.html
- National Institutes of Health. Telehealth and rural health access in the United States. Accessed January 2025. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7681127/
- Centanni M, Gargano L, Canettieri G, et al. Thyroxine in goiter, Helicobacter pylori infection, and chronic gastritis. N Engl J Med. 2006;354(17):1787-1795. https://pubmed.ncbi.nlm.nih.gov/16641395/
- Cappelli C, Pirola I, De Martino E, et al. The role of liquid levothyroxine preparation in patients with gastric-related T4 malabsorption. Thyroid. 2013;23(2):245-248. https://pubmed.ncbi.nlm.nih.gov/23025581/
- Garber JR, Cobin RH, Gharib H, et al. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Endocr Pract. 2012;18(6):988-1028. https://pubmed.ncbi.nlm.nih.gov/23246686/
- Biondi B, Wartofsky L. Treatment with thyroid hormone. Endocr Rev. 2014;35(3):433-512. https://pubmed.ncbi.nlm.nih.gov/24433442/